Spots Global Cancer Trial Database for Circulating Tumor Cells in Non-Small Cell Lung Carcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Circulating Tumor Cells in Non-Small Cell Lung Carcinoma
Official Title: Phase 2 Study of Circulating Tumor Cell in Non-Small Cell Lung Carcinoma
Study ID: NCT01830426
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to establish the circulating tumor cell (CTC) assay as a surrogate for tissue diagnosis of suspected primary lung cancer. This is done through evaluating clinical and molecular markers to stratify the outcome/survival in patients with thoracic malignancies treated at Yale University/Yale-New Haven Hospital, University of California San Diego/Moores Cancer Center, Billings Clinic Cancer Center.
Detailed Description:
Keywords
Eligibility
Minimum Age: 19 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
Moores Cancer Center, La Jolla, California, United States
Yale University, New haven, Connecticut, United States
Billings Clinic Cancer Center, Billings, Montana, United States
Contact Details
Name: Ryan Dittamore, MBA
Affiliation: Epic Sciences
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
